Applied dna submits validation package to new york state department of health to expand linea mpox virus 1.0 assay to mpox clade i

-validation studies confirmed the assay can detect mpox clade i and clade ib in addition to clade ii- stony brook, ny / accesswire / august 23, 2024 / applied dna sciences, inc. (nasdaq:apdn) (the "company"), a leader in pcr-based dna technologies, today announced that its wholly-owned clinical laboratory subsidiary, applied dna clinical labs, llc (adcl), has submitted a validation package to the new york state department of health (nysdoh) in support of an expansion of the permitted use of its linea™ mpox virus 1.0 assay (the "assay") to include both mpox clade i and clade ii. the company's validation studies concluded that the assay's primers and probe have 100% homology to mpox clade i and clade ib, the latter of which was the subject of the world health organization's (who) recently declared public health emergency of international concern.
APDN Ratings Summary
APDN Quant Ranking